Nurix Therapeutics, Inc. ( NRIX) - Key Metrics
NRIX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | ? | ? | ? | ? |
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.14 | -$0.82 | -$0.71 | -$0.77 |
| 2025Q3 | $0.09 | -$1.03 | -$0.68 | -$0.71 |
| 2025Q2 | $0.53 | -$0.52 | -$0.75 | -$0.78 |
NRIX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | ? | ? |
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -5.14 |
| 2025Q3 | ? | -2.27 |
| 2025Q2 | ? | -5.13 |
NRIX
Price: $23.36
52 week price:
Earnings Per Share: -3.22 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 161700
Market Capitalization: 2.5 billion